Showing results (381-390 of 1,534) with videos related to
Sort By:
Pageof 154
Molecular Ecology|October 24, 2024
MHC Class II Supertypes Affect Survival and Lifetime Reproductive Success in a Migratory SongbirdDavid Canal, Jacob Roved, Antonio Lara, et al.Arxiv|July 29, 2024
Genomic Language Models: Opportunities and ChallengesGonzalo Benegas, Chengzhong Ye, Carlos Albors, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: pharmacokinetic and pharmacodynamic evaluationS Guichard, A Montazeri, E Chatelut, et al.Biochemical Pharmacology|September 18, 2002
Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell lineStéphanie Arnould, Sylvie Guichard, Isabelle Hennebelle, et al.Molecular and Biochemical Parasitology|October 1, 1986
Characterization of the mechanism of protein glycosylation and the structure of glycoconjugates in tissue culture trypomastigotes and intracellular amastigotes of Trypanosoma cruziP Doyle, L de la Canal, J C Engel, et al.Ophthalmic Genetics|March 16, 2011
Choroidal melanoma and lid fibrofoliculomas in Birt-Hogg-Dubé syndromeIrene Canal Fontcuberta, Diva R Salomão, Polly A Quiram, et al.Cancer Chemotherapy and Pharmacology|July 8, 1998
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in miceS Guichard, E Chatelut, I Lochon, et al.Cancer Research|December 15, 1994
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patientsL P Rivory, E Chatelut, P Canal, et al.Neurology|August 1, 1987
Peripheral neuropathy associated with Crohn's diseaseR Nemni, R Fazio, M Corbo, et al.Biomedizinische Technik. Biomedical Engineering|August 5, 2019
A novel approach to the diagnostic assessment of carpal tunnel syndrome based on the frequency domain of the compound muscle action potentialVeysel Alcan, Hilal Kaya, Murat Zinnuroğlu, et al.Pageof 154